| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9835 | 
      | Human Intestinal Absorption | HIA+ | 1.0000 | 
      | Caco-2 Permeability | Caco2+ | 0.8943 | 
      | P-glycoprotein Substrate | Substrate | 0.6036 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.5133 | 
                                                     | Non-inhibitor | 0.8114 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7910 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6709 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7459 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9292 | 
      | CYP450 3A4 Substrate | Substrate | 0.7431 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7338 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9397 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9672 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8086 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8474 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9330 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9314 | 
                                                                    | Non-inhibitor | 0.6661 | 
      | AMES Toxicity | Non AMES toxic | 0.9268 | 
      | Carcinogens | Non-carcinogens | 0.9287 | 
      | Fish Toxicity | High FHMT | 0.9843 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9857 | 
      | Honey Bee Toxicity | High HBT | 0.7975 | 
      | Biodegradation | Not ready biodegradable | 0.9830 | 
      | Acute Oral Toxicity | III | 0.7590 | 
      | Carcinogenicity (Three-class) | Non-required | 0.4857 |